D
Nu Skin Enterprises, Inc.
NUS
$8.04
$0.091.13%
D
Sell
5/2/2024Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to D from D+ on 5/2/2024 due to a significant decline in the valuation index, efficiency index and volatility index.
Nu Skin Enterprises, Inc. (NUS) was downgraded to D from D+ on 5/2/2024 due to a significant decline in the valuation index, efficiency index and volatility index.
D
Sell
1/31/2024Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to D+ from D on 1/31/2024 due to an increase in the volatility index and valuation index.
Nu Skin Enterprises, Inc. (NUS) was upgraded to D+ from D on 1/31/2024 due to an increase in the volatility index and valuation index.
D
Sell
1/16/2024Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to D from D+ on 1/16/2024 due to a noticeable decline in the growth index, volatility index and efficiency index. Earnings per share declined from $0.5386 to -$0.7412, net income declined 237.42% from $26.89M to -$36.96M, and EBIT declined 162.03% from $42.51M to -$26.37M.
Nu Skin Enterprises, Inc. (NUS) was downgraded to D from D+ on 1/16/2024 due to a noticeable decline in the growth index, volatility index and efficiency index. Earnings per share declined from $0.5386 to -$0.7412, net income declined 237.42% from $26.89M to -$36.96M, and EBIT declined 162.03% from $42.51M to -$26.37M.
D
Sell
9/22/2023Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to D+ from C- on 9/22/2023 due to a decline in the total return index and volatility index.
Nu Skin Enterprises, Inc. (NUS) was downgraded to D+ from C- on 9/22/2023 due to a decline in the total return index and volatility index.
C
Hold
9/7/2023Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to C- from D+ on 9/7/2023 due to an increase in the valuation index and volatility index.
Nu Skin Enterprises, Inc. (NUS) was upgraded to C- from D+ on 9/7/2023 due to an increase in the valuation index and volatility index.
D
Sell
8/18/2023Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to D+ from C- on 8/18/2023 due to a decline in the volatility index and total return index.
Nu Skin Enterprises, Inc. (NUS) was downgraded to D+ from C- on 8/18/2023 due to a decline in the volatility index and total return index.
C
Hold
8/3/2023Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to C- from D+ on 8/3/2023 due to a noticeable increase in the growth index, valuation index and dividend index. Operating cash flow increased 260.9% from -$22.08M to $35.52M, earnings per share increased from $0.2292 to $0.5386, and EBIT increased 64.43% from $25.85M to $42.51M.
Nu Skin Enterprises, Inc. (NUS) was upgraded to C- from D+ on 8/3/2023 due to a noticeable increase in the growth index, valuation index and dividend index. Operating cash flow increased 260.9% from -$22.08M to $35.52M, earnings per share increased from $0.2292 to $0.5386, and EBIT increased 64.43% from $25.85M to $42.51M.
D
Sell
7/7/2023Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to D+ from C- on 7/7/2023 due to a decline in the volatility index and total return index.
Nu Skin Enterprises, Inc. (NUS) was downgraded to D+ from C- on 7/7/2023 due to a decline in the volatility index and total return index.
C
Hold
5/23/2023Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to C- from C on 5/23/2023 due to a noticeable decline in the growth index, valuation index and efficiency index. Operating cash flow declined 186.49% from $25.53M to -$22.08M, net income declined 80.12% from $57.22M to $11.38M, and earnings per share declined from $1.1412 to $0.2292.
Nu Skin Enterprises, Inc. (NUS) was downgraded to C- from C on 5/23/2023 due to a noticeable decline in the growth index, valuation index and efficiency index. Operating cash flow declined 186.49% from $25.53M to -$22.08M, net income declined 80.12% from $57.22M to $11.38M, and earnings per share declined from $1.1412 to $0.2292.
C
Hold
2/17/2023Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to C from C- on 2/17/2023 due to a significant increase in the valuation index, growth index and total return index. EBIT increased 365.74% from $9.84M to $45.83M, and earnings per share increased from -$0.51 to $1.1412.
Nu Skin Enterprises, Inc. (NUS) was upgraded to C from C- on 2/17/2023 due to a significant increase in the valuation index, growth index and total return index. EBIT increased 365.74% from $9.84M to $45.83M, and earnings per share increased from -$0.51 to $1.1412.
C
Hold
12/16/2022Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to C- from D+ on 12/16/2022 due to an increase in the volatility index.
Nu Skin Enterprises, Inc. (NUS) was upgraded to C- from D+ on 12/16/2022 due to an increase in the volatility index.
D
Sell
12/1/2022Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to D+ from C- on 12/1/2022 due to a significant decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.67 to -$0.51, net income declined 174.16% from $34.24M to -$25.39M, and EBIT declined 80.9% from $51.53M to $9.84M.
Nu Skin Enterprises, Inc. (NUS) was downgraded to D+ from C- on 12/1/2022 due to a significant decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.67 to -$0.51, net income declined 174.16% from $34.24M to -$25.39M, and EBIT declined 80.9% from $51.53M to $9.84M.
C
Hold
10/14/2022Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to C- from C on 10/14/2022 due to a decline in the growth index, total return index and volatility index. Earnings per share declined from $0.76 to $0.67, total revenue declined 7.32% from $604.9M to $560.62M, and EBIT declined 1.19% from $52.15M to $51.53M.
Nu Skin Enterprises, Inc. (NUS) was downgraded to C- from C on 10/14/2022 due to a decline in the growth index, total return index and volatility index. Earnings per share declined from $0.76 to $0.67, total revenue declined 7.32% from $604.9M to $560.62M, and EBIT declined 1.19% from $52.15M to $51.53M.
C
Hold
7/25/2022Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to C from C+ on 7/25/2022 due to a decline in the total return index.
Nu Skin Enterprises, Inc. (NUS) was downgraded to C from C+ on 7/25/2022 due to a decline in the total return index.
C
Hold
7/5/2022Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to C+ from C on 7/5/2022 due to a noticeable increase in the volatility index.
Nu Skin Enterprises, Inc. (NUS) was upgraded to C+ from C on 7/5/2022 due to a noticeable increase in the volatility index.
C
Hold
5/6/2022Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to C from C- on 5/6/2022 due to a large increase in the growth index, solvency index and dividend index. Earnings per share increased from -$0.1876 to $0.76, debt to equity declined from 0.45 to 0.43, and the quick ratio increased from 0.75 to 0.75.
Nu Skin Enterprises, Inc. (NUS) was upgraded to C from C- on 5/6/2022 due to a large increase in the growth index, solvency index and dividend index. Earnings per share increased from -$0.1876 to $0.76, debt to equity declined from 0.45 to 0.43, and the quick ratio increased from 0.75 to 0.75.
C
Hold
5/4/2022Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to C- from C on 5/4/2022 due to a decline in the volatility index and total return index.
Nu Skin Enterprises, Inc. (NUS) was downgraded to C- from C on 5/4/2022 due to a decline in the volatility index and total return index.
C
Hold
4/18/2022Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to C from C- on 4/18/2022 due to an increase in the dividend index, total return index and solvency index.
Nu Skin Enterprises, Inc. (NUS) was upgraded to C from C- on 4/18/2022 due to an increase in the dividend index, total return index and solvency index.
C
Hold
3/15/2022Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to C- from C on 3/15/2022 due to a decline in the volatility index and total return index.
Nu Skin Enterprises, Inc. (NUS) was downgraded to C- from C on 3/15/2022 due to a decline in the volatility index and total return index.
C
Hold
2/17/2022Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to C from C+ on 2/17/2022 due to a major decline in the growth index, valuation index and dividend index. Earnings per share declined from $0.97 to -$0.1851.
Nu Skin Enterprises, Inc. (NUS) was downgraded to C from C+ on 2/17/2022 due to a major decline in the growth index, valuation index and dividend index. Earnings per share declined from $0.97 to -$0.1851.
C
Hold
2/11/2022Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to C+ from C on 2/11/2022 due to an increase in the volatility index and efficiency index.
Nu Skin Enterprises, Inc. (NUS) was upgraded to C+ from C on 2/11/2022 due to an increase in the volatility index and efficiency index.
C
Hold
9/22/2021Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to C from C+ on 9/22/2021 due to a decline in the total return index, growth index and volatility index.
Nu Skin Enterprises, Inc. (NUS) was downgraded to C from C+ on 9/22/2021 due to a decline in the total return index, growth index and volatility index.
C
Hold
8/4/2021Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to C+ from C on 8/4/2021 due to an increase in the total return index, volatility index and valuation index.
Nu Skin Enterprises, Inc. (NUS) was upgraded to C+ from C on 8/4/2021 due to an increase in the total return index, volatility index and valuation index.
C
Hold
7/20/2021Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to C from C+ on 7/20/2021 due to a noticeable decline in the total return index.
Nu Skin Enterprises, Inc. (NUS) was downgraded to C from C+ on 7/20/2021 due to a noticeable decline in the total return index.
C
Hold
6/3/2021Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to C+ from C on 6/3/2021 due to a large increase in the total return index and valuation index.
Nu Skin Enterprises, Inc. (NUS) was upgraded to C+ from C on 6/3/2021 due to a large increase in the total return index and valuation index.
C
Hold
2/23/2021Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to C from C+ on 2/23/2021 due to a decline in the total return index.
Nu Skin Enterprises, Inc. (NUS) was downgraded to C from C+ on 2/23/2021 due to a decline in the total return index.
C
Hold
2/1/2021Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to C+ from C on 2/1/2021 due to an increase in the total return index, growth index and efficiency index.
Nu Skin Enterprises, Inc. (NUS) was upgraded to C+ from C on 2/1/2021 due to an increase in the total return index, growth index and efficiency index.
C
Hold
1/12/2021Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to C from C+ on 1/12/2021 due to a decline in the total return index, valuation index and dividend index.
Nu Skin Enterprises, Inc. (NUS) was downgraded to C from C+ on 1/12/2021 due to a decline in the total return index, valuation index and dividend index.
C
Hold
12/28/2020Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to C+ from C on 12/28/2020 due to a significant increase in the growth index, total return index and volatility index. Earnings per share increased from $0.8068 to $1.08, EBIT increased 27.82% from $58.07M to $74.23M, and operating cash flow increased 21.96% from $97.05M to $118.37M.
Nu Skin Enterprises, Inc. (NUS) was upgraded to C+ from C on 12/28/2020 due to a significant increase in the growth index, total return index and volatility index. Earnings per share increased from $0.8068 to $1.08, EBIT increased 27.82% from $58.07M to $74.23M, and operating cash flow increased 21.96% from $97.05M to $118.37M.
C
Hold
7/16/2020Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to C from C- on 7/16/2020 due to an increase in the total return index and volatility index.
Nu Skin Enterprises, Inc. (NUS) was upgraded to C from C- on 7/16/2020 due to an increase in the total return index and volatility index.
C
Hold
6/5/2020Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to C- from D+ on 6/5/2020 due to an increase in the total return index and volatility index.
Nu Skin Enterprises, Inc. (NUS) was upgraded to C- from D+ on 6/5/2020 due to an increase in the total return index and volatility index.
D
Sell
4/23/2020Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to D+ from C- on 4/23/2020 due to a decline in the total return index, valuation index and volatility index.
Nu Skin Enterprises, Inc. (NUS) was downgraded to D+ from C- on 4/23/2020 due to a decline in the total return index, valuation index and volatility index.
C
Hold
4/8/2020Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to C- from D+ on 4/8/2020 due to an increase in the volatility index.
Nu Skin Enterprises, Inc. (NUS) was upgraded to C- from D+ on 4/8/2020 due to an increase in the volatility index.
D
Sell
3/20/2020Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to D+ from C- on 3/20/2020 due to a decline in the total return index, solvency index and volatility index.
Nu Skin Enterprises, Inc. (NUS) was downgraded to D+ from C- on 3/20/2020 due to a decline in the total return index, solvency index and volatility index.
C
Hold
8/6/2019Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to C- from C on 8/6/2019 due to a large decline in the volatility index, total return index and efficiency index.
Nu Skin Enterprises, Inc. (NUS) was downgraded to C- from C on 8/6/2019 due to a large decline in the volatility index, total return index and efficiency index.
C
Hold
2/15/2019Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to C from C+ on 2/15/2019 due to a significant decline in the growth index, valuation index and solvency index. Earnings per share declined from $0.94 to -$0.3203, the quick ratio declined from 1.07 to 1.03, and debt to equity increased from 0.54 to 0.55.
Nu Skin Enterprises, Inc. (NUS) was downgraded to C from C+ on 2/15/2019 due to a significant decline in the growth index, valuation index and solvency index. Earnings per share declined from $0.94 to -$0.3203, the quick ratio declined from 1.07 to 1.03, and debt to equity increased from 0.54 to 0.55.
C
Hold
1/30/2019Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to C+ from B- on 1/30/2019 due to a decline in the total return index and volatility index.
Nu Skin Enterprises, Inc. (NUS) was downgraded to C+ from B- on 1/30/2019 due to a decline in the total return index and volatility index.
B
Buy
12/17/2018Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to B- from B on 12/17/2018 due to a decline in the total return index and volatility index.
Nu Skin Enterprises, Inc. (NUS) was downgraded to B- from B on 12/17/2018 due to a decline in the total return index and volatility index.
B
Buy
11/14/2018Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to B from B- on 11/14/2018 due to a noticeable increase in the growth index, valuation index and solvency index. Operating cash flow increased 16.72% from $53.05M to $61.92M, debt to equity declined from 0.58 to 0.54, and earnings per share increased from $0.9 to $0.94.
Nu Skin Enterprises, Inc. (NUS) was upgraded to B from B- on 11/14/2018 due to a noticeable increase in the growth index, valuation index and solvency index. Operating cash flow increased 16.72% from $53.05M to $61.92M, debt to equity declined from 0.58 to 0.54, and earnings per share increased from $0.9 to $0.94.
B
Buy
10/23/2018Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to B- from B on 10/23/2018 due to a noticeable decline in the total return index and volatility index.
Nu Skin Enterprises, Inc. (NUS) was downgraded to B- from B on 10/23/2018 due to a noticeable decline in the total return index and volatility index.
B
Buy
10/8/2018Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to B from B- on 10/8/2018 due to an increase in the volatility index.
Nu Skin Enterprises, Inc. (NUS) was upgraded to B from B- on 10/8/2018 due to an increase in the volatility index.
B
Buy
9/7/2018Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to B- from B on 9/7/2018 due to a large decline in the total return index.
Nu Skin Enterprises, Inc. (NUS) was downgraded to B- from B on 9/7/2018 due to a large decline in the total return index.
B
Buy
8/14/2018Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to B from B- on 8/14/2018 due to a large increase in the growth index, total return index and volatility index. Operating cash flow increased 4,866.04% from -$1.11M to $53.05M, earnings per share increased from $0.64 to $0.9, and EBIT increased 40.3% from $58.99M to $82.76M.
Nu Skin Enterprises, Inc. (NUS) was upgraded to B from B- on 8/14/2018 due to a large increase in the growth index, total return index and volatility index. Operating cash flow increased 4,866.04% from -$1.11M to $53.05M, earnings per share increased from $0.64 to $0.9, and EBIT increased 40.3% from $58.99M to $82.76M.
B
Buy
6/19/2018Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to B- from C+ on 6/19/2018 due to a large increase in the total return index, volatility index and efficiency index. Net income increased 94.89% from $18.24M to $35.54M, and total capital increased 16.08% from $1.09B to $1.27B.
Nu Skin Enterprises, Inc. (NUS) was upgraded to B- from C+ on 6/19/2018 due to a large increase in the total return index, volatility index and efficiency index. Net income increased 94.89% from $18.24M to $35.54M, and total capital increased 16.08% from $1.09B to $1.27B.
C
Hold
8/4/2017Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to C+ from C on 8/4/2017 due to a significant increase in the growth index, total return index and volatility index. Operating cash flow increased 194% from $21.33M to $62.7M, earnings per share increased from $0.51 to $0.77, and EBIT increased 39.94% from $46.26M to $64.74M.
Nu Skin Enterprises, Inc. (NUS) was upgraded to C+ from C on 8/4/2017 due to a significant increase in the growth index, total return index and volatility index. Operating cash flow increased 194% from $21.33M to $62.7M, earnings per share increased from $0.51 to $0.77, and EBIT increased 39.94% from $46.26M to $64.74M.
C
Hold
3/30/2017Upgraded
Nu Skin Enterprises, Inc. (NUS) was upgraded to C from C- on 3/30/2017 due to an increase in the volatility index, solvency index and total return index.
Nu Skin Enterprises, Inc. (NUS) was upgraded to C from C- on 3/30/2017 due to an increase in the volatility index, solvency index and total return index.
C
Hold
2/27/2017Downgrade
Nu Skin Enterprises, Inc. (NUS) was downgraded to C- from C on 2/27/2017 due to a large decline in the growth index, volatility index and efficiency index. Net income declined 32.86% from $56.87M to $38.19M, earnings per share declined from $0.98 to $0.6907, and EBIT declined 26.21% from $82.37M to $60.78M.
Nu Skin Enterprises, Inc. (NUS) was downgraded to C- from C on 2/27/2017 due to a large decline in the growth index, volatility index and efficiency index. Net income declined 32.86% from $56.87M to $38.19M, earnings per share declined from $0.98 to $0.6907, and EBIT declined 26.21% from $82.37M to $60.78M.
C
Hold
8/5/2016Upgraded
Nu Skin Enterprises Inc. (NUS) was upgraded to C from C- on 8/5/2016 due to a major increase in the growth index, volatility index and solvency index. Operating cash flow increased 5,200.92% from -$2.72M to $138.54M, earnings per share increased from $0.0593 to $0.79, and EBIT increased 879.24% from $8.15M to $79.8M.
Nu Skin Enterprises Inc. (NUS) was upgraded to C from C- on 8/5/2016 due to a major increase in the growth index, volatility index and solvency index. Operating cash flow increased 5,200.92% from -$2.72M to $138.54M, earnings per share increased from $0.0593 to $0.79, and EBIT increased 879.24% from $8.15M to $79.8M.
C
Hold
6/1/2016Upgraded
Nu Skin Enterprises Inc. (NUS) was upgraded to C- from D+ on 6/1/2016 due to an increase in the total return index, volatility index and valuation index.
Nu Skin Enterprises Inc. (NUS) was upgraded to C- from D+ on 6/1/2016 due to an increase in the total return index, volatility index and valuation index.
D
Sell
4/29/2016Downgrade
Nu Skin Enterprises Inc. (NUS) was downgraded to D+ from C- on 4/29/2016 due to a large decline in the growth index, valuation index and efficiency index. Operating cash flow declined 103.39% from $80.15M to -$2.72M, net income declined 90.75% from $35.84M to $3.32M, and earnings per share declined from $0.6221 to $0.0593.
Nu Skin Enterprises Inc. (NUS) was downgraded to D+ from C- on 4/29/2016 due to a large decline in the growth index, valuation index and efficiency index. Operating cash flow declined 103.39% from $80.15M to -$2.72M, net income declined 90.75% from $35.84M to $3.32M, and earnings per share declined from $0.6221 to $0.0593.
C
Hold
3/11/2016Downgrade
Nu Skin Enterprises Inc. (NUS) was downgraded to C- from B- on 3/11/2016 due to a major decline in the volatility index, total return index and valuation index.
Nu Skin Enterprises Inc. (NUS) was downgraded to C- from B- on 3/11/2016 due to a major decline in the volatility index, total return index and valuation index.
B
Buy
2/29/2016Upgraded
Nu Skin Enterprises Inc. (NUS) was upgraded to B- from C+ on 2/29/2016 due to an increase in the valuation index, total return index and dividend index.
Nu Skin Enterprises Inc. (NUS) was upgraded to B- from C+ on 2/29/2016 due to an increase in the valuation index, total return index and dividend index.
C
Hold
2/19/2016Upgraded
Nu Skin Enterprises Inc. (NUS) was upgraded to C+ from C on 2/19/2016 due to a noticeable increase in the growth index, efficiency index and valuation index. Earnings per share increased from $0.28 to $0.6221, net income increased 120.32% from $16.27M to $35.84M, and EBIT increased 45.07% from $42.54M to $61.71M.
Nu Skin Enterprises Inc. (NUS) was upgraded to C+ from C on 2/19/2016 due to a noticeable increase in the growth index, efficiency index and valuation index. Earnings per share increased from $0.28 to $0.6221, net income increased 120.32% from $16.27M to $35.84M, and EBIT increased 45.07% from $42.54M to $61.71M.
C
Hold
1/12/2016Downgrade
Nu Skin Enterprises Inc. (NUS) was downgraded to C from C+ on 1/12/2016 due to a decline in the total return index.
Nu Skin Enterprises Inc. (NUS) was downgraded to C from C+ on 1/12/2016 due to a decline in the total return index.
C
Hold
12/28/2015Upgraded
Nu Skin Enterprises Inc. (NUS) was upgraded to C+ from C on 12/28/2015 due to an increase in the total return index and valuation index.
Nu Skin Enterprises Inc. (NUS) was upgraded to C+ from C on 12/28/2015 due to an increase in the total return index and valuation index.
C
Hold
11/5/2015Downgrade
Nu Skin Enterprises Inc. (NUS) was downgraded to C from B- on 11/5/2015 due to a significant decline in the growth index, valuation index and solvency index. Earnings per share declined from $0.75 to $0.28, EBIT declined 40.75% from $71.8M to $42.54M, and debt to equity increased from 0.28 to 0.29.
Nu Skin Enterprises Inc. (NUS) was downgraded to C from B- on 11/5/2015 due to a significant decline in the growth index, valuation index and solvency index. Earnings per share declined from $0.75 to $0.28, EBIT declined 40.75% from $71.8M to $42.54M, and debt to equity increased from 0.28 to 0.29.
B
Buy
10/22/2015Upgraded
Nu Skin Enterprises Inc. (NUS) was upgraded to B- from C+ on 10/22/2015 due to an increase in the valuation index and dividend index.
Nu Skin Enterprises Inc. (NUS) was upgraded to B- from C+ on 10/22/2015 due to an increase in the valuation index and dividend index.
C
Hold
9/16/2015Downgrade
Nu Skin Enterprises Inc. (NUS) was downgraded to C+ from B- on 9/16/2015 due to a decline in the valuation index, total return index and dividend index.
Nu Skin Enterprises Inc. (NUS) was downgraded to C+ from B- on 9/16/2015 due to a decline in the valuation index, total return index and dividend index.
B
Buy
8/7/2015Upgraded
Nu Skin Enterprises Inc. (NUS) was upgraded to B- from C+ on 8/7/2015 due to a significant increase in the growth index, valuation index and solvency index. Earnings per share increased from $0.6 to $0.75, operating cash flow increased 15.1% from $74.2M to $85.4M, and EBIT increased 4.6% from $68.65M to $71.8M.
Nu Skin Enterprises Inc. (NUS) was upgraded to B- from C+ on 8/7/2015 due to a significant increase in the growth index, valuation index and solvency index. Earnings per share increased from $0.6 to $0.75, operating cash flow increased 15.1% from $74.2M to $85.4M, and EBIT increased 4.6% from $68.65M to $71.8M.
C
Hold
7/24/2015Upgraded
Nu Skin Enterprises Inc. (NUS) was upgraded to C+ from C on 7/24/2015 due to an increase in the valuation index and dividend index.
Nu Skin Enterprises Inc. (NUS) was upgraded to C+ from C on 7/24/2015 due to an increase in the valuation index and dividend index.
C
Hold
7/9/2015Downgrade
Nu Skin Enterprises Inc. (NUS) was downgraded to C from C+ on 7/9/2015 due to a decline in the volatility index and total return index.
Nu Skin Enterprises Inc. (NUS) was downgraded to C from C+ on 7/9/2015 due to a decline in the volatility index and total return index.
C
Hold
6/24/2015Downgrade
Nu Skin Enterprises Inc. (NUS) was downgraded to C+ from B- on 6/24/2015 due to a decline in the total return index and solvency index.
Nu Skin Enterprises Inc. (NUS) was downgraded to C+ from B- on 6/24/2015 due to a decline in the total return index and solvency index.
B
Buy
5/8/2015Downgrade
Nu Skin Enterprises Inc. (NUS) was downgraded to B- from B on 5/8/2015 due to a noticeable decline in the growth index, volatility index and valuation index. EBIT declined 24.81% from $91.3M to $68.65M, earnings per share declined from $0.7709 to $0.6, and operating cash flow declined 21.73% from $94.79M to $74.2M.
Nu Skin Enterprises Inc. (NUS) was downgraded to B- from B on 5/8/2015 due to a noticeable decline in the growth index, volatility index and valuation index. EBIT declined 24.81% from $91.3M to $68.65M, earnings per share declined from $0.7709 to $0.6, and operating cash flow declined 21.73% from $94.79M to $74.2M.
B
Buy
5/1/2015Upgraded
Nu Skin Enterprises Inc. (NUS) was upgraded to B from B- on 5/1/2015 due to an increase in the volatility index, valuation index and total return index.
Nu Skin Enterprises Inc. (NUS) was upgraded to B from B- on 5/1/2015 due to an increase in the volatility index, valuation index and total return index.
B
Buy
3/31/2015Upgraded
Nu Skin Enterprises Inc. (NUS) was upgraded to B- from C+ on 3/31/2015 due to an increase in the volatility index and total return index.
Nu Skin Enterprises Inc. (NUS) was upgraded to B- from C+ on 3/31/2015 due to an increase in the volatility index and total return index.
C
Hold
3/16/2015Downgrade
Nu Skin Enterprises Inc. (NUS) was downgraded to C+ from B- on 3/16/2015 due to a noticeable decline in the valuation index, growth index and volatility index. Earnings per share declined from $1.12 to $0.7709, EBIT declined 13.01% from $104.96M to $91.3M, and total revenue declined 4.57% from $638.8M to $609.61M.
Nu Skin Enterprises Inc. (NUS) was downgraded to C+ from B- on 3/16/2015 due to a noticeable decline in the valuation index, growth index and volatility index. Earnings per share declined from $1.12 to $0.7709, EBIT declined 13.01% from $104.96M to $91.3M, and total revenue declined 4.57% from $638.8M to $609.61M.
B
Buy
3/2/2015Downgrade
Nu Skin Enterprises Inc. (NUS) was downgraded to B- from B on 3/2/2015 due to a decline in the valuation index, volatility index and dividend index.
Nu Skin Enterprises Inc. (NUS) was downgraded to B- from B on 3/2/2015 due to a decline in the valuation index, volatility index and dividend index.
B
Buy
2/10/2015Upgraded
Nu Skin Enterprises Inc. (NUS) was upgraded to B from B- on 2/10/2015 due to an increase in the volatility index and total return index.
Nu Skin Enterprises Inc. (NUS) was upgraded to B from B- on 2/10/2015 due to an increase in the volatility index and total return index.
B
Buy
1/26/2015Downgrade
Nu Skin Enterprises Inc. (NUS) was downgraded to B- from B on 1/26/2015 due to a large decline in the volatility index and total return index.
Nu Skin Enterprises Inc. (NUS) was downgraded to B- from B on 1/26/2015 due to a large decline in the volatility index and total return index.
B
Buy
1/5/2015Downgrade
Nu Skin Enterprises Inc. (NUS) was downgraded to B from B+ on 1/5/2015 due to a decline in the total return index, valuation index and volatility index.
Nu Skin Enterprises Inc. (NUS) was downgraded to B from B+ on 1/5/2015 due to a decline in the total return index, valuation index and volatility index.
B
Buy
12/19/2014Upgraded
Nu Skin Enterprises Inc. (NUS) was upgraded to B+ from B on 12/19/2014 due to a substantial increase in the volatility index.
Nu Skin Enterprises Inc. (NUS) was upgraded to B+ from B on 12/19/2014 due to a substantial increase in the volatility index.
B
Buy
11/21/2014Upgraded
Nu Skin Enterprises Inc. (NUS) was upgraded to B from B- on 11/21/2014 due to an increase in the volatility index and dividend index.
Nu Skin Enterprises Inc. (NUS) was upgraded to B from B- on 11/21/2014 due to an increase in the volatility index and dividend index.
B
Buy
11/10/2014Downgrade
Nu Skin Enterprises Inc. (NUS) was downgraded to B- from B on 11/10/2014 due to a noticeable decline in the total return index, volatility index and growth index. Operating cash flow declined 84.89% from -$160.6M to -$24.27M, earnings per share declined from $0.9 to $0.32, and EBIT declined 45.91% from $101.2M to $54.74M.
Nu Skin Enterprises Inc. (NUS) was downgraded to B- from B on 11/10/2014 due to a noticeable decline in the total return index, volatility index and growth index. Operating cash flow declined 84.89% from -$160.6M to -$24.27M, earnings per share declined from $0.9 to $0.32, and EBIT declined 45.91% from $101.2M to $54.74M.
B
Buy
7/28/2014Downgrade
Nu Skin Enterprises Inc. (NUS) was downgraded to B from B+ on 7/28/2014 due to a decline in the volatility index and total return index.
Nu Skin Enterprises Inc. (NUS) was downgraded to B from B+ on 7/28/2014 due to a decline in the volatility index and total return index.
B
Buy
7/11/2014Upgraded
Nu Skin Enterprises Inc. (NUS) was upgraded to B+ from B on 7/11/2014 due to an increase in the volatility index, valuation index and total return index.
Nu Skin Enterprises Inc. (NUS) was upgraded to B+ from B on 7/11/2014 due to an increase in the volatility index, valuation index and total return index.
B
Buy
6/6/2014Downgrade
Nu Skin Enterprises Inc. (NUS) was downgraded to B from B+ on 6/6/2014 due to a decline in the volatility index, valuation index and dividend index.
Nu Skin Enterprises Inc. (NUS) was downgraded to B from B+ on 6/6/2014 due to a decline in the volatility index, valuation index and dividend index.
B
Buy
5/28/2014Downgrade
Nu Skin Enterprises Inc. (NUS) was downgraded to B+ from A- on 5/28/2014 due to a major decline in the growth index, volatility index and solvency index. Operating cash flow declined 448.88% from $46.03M to -$160.6M, earnings per share declined from $2.0293 to $1.05, and EBIT declined 46.34% from $188.6M to $101.2M.
Nu Skin Enterprises Inc. (NUS) was downgraded to B+ from A- on 5/28/2014 due to a major decline in the growth index, volatility index and solvency index. Operating cash flow declined 448.88% from $46.03M to -$160.6M, earnings per share declined from $2.0293 to $1.05, and EBIT declined 46.34% from $188.6M to $101.2M.
A
Buy
3/20/2014Downgrade
Nu Skin Enterprises Inc. (NUS) was downgraded to A- from A on 3/20/2014 due to a decline in the growth index, volatility index and solvency index. Operating cash flow declined 84.41% from $295.29M to $46.03M, and the quick ratio declined from 0.87 to 0.8.
Nu Skin Enterprises Inc. (NUS) was downgraded to A- from A on 3/20/2014 due to a decline in the growth index, volatility index and solvency index. Operating cash flow declined 84.41% from $295.29M to $46.03M, and the quick ratio declined from 0.87 to 0.8.
NYSE
03/10/2025 1:00PM Eastern
Quotes delayed
